People seem to see what they want to see. Most of it is a mirage. This DTRA stuff has no mention of Peregrine or Bavituximab that I can see. All conjecture at this point. IMO we would have a PR if we got more funding since the original PR was not a concrete amount. Just how much we could get if the data looked promising. So far even the data is a mirage.
Someone posted about some new Haynes publications a couple of days ago and I don't recall one post in reply. I see a dozen posts on this DTRA find, many posts directed at realist or other off topic subjects, and few if any on these publications which are an actual fact.
Why didn't Tustin PR the latest patent? They Pr'd 3 previous ones this year.
Market Data 
Markets 
AI
